Hybrida Farms Market Research Report

Background

Company Overview

Hybrida Farms is Costa Rica's first dual-licensed cultivator for both medical cannabis and hemp, specializing in large-scale contract cultivation of cannabinoid-rich medical cannabis. The company combines natural sun-grown methods with advanced greenhouse systems and precision agronomy to produce consistent, high-quality flower for extraction and medical formulation on a global scale.

Mission and Vision

Hybrida Farms is committed to delivering potent, clean, and ethically cultivated medical cannabis to the world, while leading the industry in environmental responsibility and cultivation innovation. The company aims to set a new global standard for quality, consistency, and versatility in cannabis products.

Industry Significance

As Costa Rica's first dual-licensed cultivator for medical cannabis and hemp, Hybrida Farms plays a pivotal role in the emerging cannabis export sector, positioning the country as a competitive player in the global pharmaceutical cannabis market.

Key Strategic Focus

Core Objectives

• Sustainable Cultivation: Implementing environmentally responsible practices to minimize the ecological footprint.

• Global Expansion: Establishing a robust international supply chain to meet the growing demand for medical cannabis.

• Regulatory Compliance: Ensuring adherence to international standards and regulations for pharmaceutical-grade products.

Areas of Specialization

• Contract Cultivation: Providing scalable medical-grade flower supply tailored to client specifications.

• Genetic Development: Maintaining an extensive registered genetics library for consistent and high-quality yields.

• Tissue Culture Propagation: Utilizing advanced in-vitro propagation techniques for rapid, disease-free plant multiplication.

Key Technologies Utilized

• Automated Fertigation Systems: Employing custom-designed fertigation systems for precise nutrient and water delivery.

• Renewable Energy Integration: Operating facilities powered by over 95% renewable energy sources, including hydroelectric, geothermal, and solar power.

Primary Markets Targeted

• Pharmaceutical Companies: Supplying high-quality, ethically cultivated medical cannabis for pharmaceutical applications.

• International Distributors: Establishing partnerships to distribute products globally, particularly in the European Union.

Financials and Funding

Funding History

As of May 2026, Hybrida Farms has not publicly disclosed any external funding rounds or investments. The company operates with a focus on sustainable growth and has not reported significant external funding.

Financial Performance

The company has reported annual revenues of approximately $1.45 million, with an estimated valuation of $4.7 million. This valuation is based on industry averages for the farming sector and current revenue estimates.

Pipeline Development

Key Pipeline Candidates

• Medical Cannabis Flower: Cultivating high-quality, cannabinoid-rich medical cannabis for pharmaceutical applications.

• Hemp Products: Developing hemp-based products for various industrial and consumer applications.

Stages of Development

• Cultivation: Ongoing large-scale cultivation with a focus on quality and consistency.

• Processing: Implementing processing facilities to prepare products for export and distribution.

Target Conditions

• Medical Cannabis: Targeting conditions that benefit from cannabinoid therapies, including chronic pain, epilepsy, and anxiety disorders.

• Hemp Products: Focusing on applications in textiles, construction materials, and health supplements.

Anticipated Milestones

• EU Export: Successfully completed Costa Rica's first export of pharmaceutical-grade medical cannabis to the European Union in March 2026.

• Facility Expansion: Plans to expand cultivation capacity to meet increasing global demand.

Technological Platform and Innovation

Proprietary Technologies

• Tissue Culture Lab: An in-house facility for pathogen-free genetic propagation, ensuring strong genetics and disease-free plants.

• Custom Fertigation System: A precision system designed in collaboration with H.E. Anderson, Ceres, and Soilscape Solutions for efficient nutrient and water delivery.

Significant Scientific Methods

• In-Vitro Propagation: Utilizing advanced tissue culture techniques for rapid and disease-free plant multiplication.

• Automated Data-Driven Agriculture: Implementing automated systems for monitoring and optimizing cultivation conditions.

Leadership Team

Key Executives

• Craig Aumann: Chief Executive Officer

• Riley Shields: Director of Cultivation

• Jorge Luis Calderón Chaves: President

Professional Backgrounds

• Craig Aumann: CEO with extensive experience in agricultural management and international business development.

• Riley Shields: Director of Cultivation with expertise in large-scale cannabis cultivation and sustainable farming practices.

• Jorge Luis Calderón Chaves: President with a background in agricultural policy and international trade.

Key Contributions

• Craig Aumann: Led the strategic direction and international expansion of Hybrida Farms.

• Riley Shields: Implemented advanced cultivation techniques and managed the expansion of cultivation facilities.

• Jorge Luis Calderón Chaves: Oversaw regulatory compliance and international trade initiatives.